BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9426443)

  • 1. Transformation of primary chick embryo fibroblasts by Marek's disease virus.
    Buranathai C; Rodriguez J; Grose C
    Virology; 1997 Dec; 239(1):20-35. PubMed ID: 9426443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a sustainable chick cell line infected with Marek's disease virus.
    Abujoub A; Coussens PM
    Virology; 1995 Dec; 214(2):541-9. PubMed ID: 8553556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional analysis of Marek's disease virus glycoprotein D, I, and E genes: gD expression is undetectable in cell culture.
    Tan X; Brunovskis P; Velicer LF
    J Virol; 2001 Mar; 75(5):2067-75. PubMed ID: 11160711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of native chicken interferon on MDV replication.
    Levy AM; Heller ED; Leitner G; Davidson I
    Acta Virol; 1999; 43(2-3):121-7. PubMed ID: 10696431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that Marek's disease virus exists in a latent state in a sustainable fibroblast cell line.
    Abujoub AA; Coussens PM
    Virology; 1997 Mar; 229(2):309-21. PubMed ID: 9126245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological characteristics of a membrane glycoprotein gp82 of Marek's disease virus.
    Wu P; Lee LF; Reed WM
    Avian Dis; 1997; 41(4):824-31. PubMed ID: 9454915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
    Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
    Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.
    Burnside J; Bernberg E; Anderson A; Lu C; Meyers BC; Green PJ; Jain N; Isaacs G; Morgan RW
    J Virol; 2006 Sep; 80(17):8778-86. PubMed ID: 16912324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens.
    Niikura M; Witter RL; Jang HK; Ono M; Mikami T; Silva RF
    Acta Virol; 1999; 43(2-3):159-63. PubMed ID: 10696438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
    Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
    Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
    Omar AR; Schat KA
    Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a cell line system susceptible to infection with vaccine strains of MDV.
    Abujoub AA; Williams DL; Reilly JD
    Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function.
    Reddy SM; Lupiani B; Gimeno IM; Silva RF; Lee LF; Witter RL
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7054-9. PubMed ID: 11997455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological cross-reaction of serotype I Marek's disease virus 38kD phosphorylated protein with serotype II and III viruses].
    Qin A; Cui Z; Duan Y
    Wei Sheng Wu Xue Bao; 1994 Oct; 34(5):393-7. PubMed ID: 7871782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the meq gene in the T cell subsets from chickens infected with Marek's disease virus serotype 1.
    Chang KS; Ohashi K; Lee SI; Takagi M; Onum M
    Jpn J Vet Res; 2005 Aug; 53(1-2):3-11. PubMed ID: 16190317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and localization of the unique Marek's disease virus type 2 ORF873 gene product.
    Jang HK
    J Vet Sci; 2004 Sep; 5(3):207-13. PubMed ID: 15365234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pp38 gene of Marek's disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV.
    Gimeno IM; Witter RL; Hunt HD; Reddy SM; Lee LF; Silva RF
    J Virol; 2005 Apr; 79(7):4545-9. PubMed ID: 15767457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.